Abstract
Background
Bacteriocins are antimicrobial proteins and peptides ribosomally synthesized by some bacteria which can effect both intraspecies and interspecies killing.
Results
Moraxella catarrhalis strain E22 containing plasmid pLQ510 was shown to inhibit the growth of M. catarrhalis strain O35E. Two genes (mcbA and mcbB) in pLQ510 encoded proteins predicted to be involved in the secretion of a bacteriocin. Immediately downstream from these two genes, a very short ORF (mcbC) encoded a protein which had some homology to double-glycine bacteriocins produced by other bacteria. A second very short ORF (mcbI) immediately downstream from mcbC encoded a protein which had no significant similarity to other proteins in the databases. Cloning and expression of the mcbI gene in M. catarrhalis O35E indicated that this gene encoded the cognate immunity factor. Reverse transcriptase-PCR was used to show that the mcbA, mcbB, mcbC, and mcbI ORFs were transcriptionally linked. This four-gene cluster was subsequently shown to be present in the chromosome of several M. catarrhalis strains including O12E. Inactivation of the mcbA, mcbB, or mcbC ORFs in M. catarrhalis O12E eliminated the ability of this strain to inhibit the growth of M. catarrhalis O35E. In co-culture experiments involving a M. catarrhalis strain containing the mcbABCI locus and one which lacked this locus, the former strain became the predominant member of the culture after overnight growth in broth.
Conclusion
This is the first description of a bacteriocin and its cognate immunity factor produced by M. catarrhalis. The killing activity of the McbC protein raises the possibility that it might serve to lyse other M. catarrhalis strains that lack the mcbABCI locus, thereby making their DNA available for lateral gene transfer.
Similar content being viewed by others
Background
Moraxella catarrhalis, formerly known as both Neisseria catarrhalis and Branhamella catarrhalis [1], is a gram-negative bacterium that can frequently be isolated from the nasopharynx of healthy persons [2–4]. For many years, M. catarrhalis was considered to be a harmless commensal [1–4]. About twenty years ago, it was acknowledged that M. catarrhalis was a pathogen of the respiratory tract [5], and since then much evidence has accumulated which indicates that M. catarrhalis causes disease in both adults and children. M. catarrhalis is one of the three most important causes of otitis media in infants and very young children [3, 6]. In adults, this bacterium can cause infectious exacerbations of chronic obstructive pulmonary disease (COPD), and one recent study estimates that, in the United States alone, M. catarrhalis may cause 2 million-4 million infectious exacerbations of COPD annually [7].
The ability of M. catarrhalis to colonize the mucosa of the upper respiratory tract (i.e., nasopharynx) is undoubtedly linked to its expression of different adhesins for various human cells and antigens [8–15]. In addition, this bacterium clearly has the metabolic capability to survive and grow in this environment in the presence of the normal flora. A recent study [16] identified a number of different metabolic pathways encoded by the M. catarrhalis ATCC 43617 genome which could be involved in the colonization process. It is likely that M. catarrhalis forms a biofilm in concert with these other bacteria in the nasopharynx [17], although only a few M. catarrhalis gene products relevant to biofilm formation have been identified to date [13, 18, 19]. Similarly, there is little known about what extracellular gene products are synthesized by M. catarrhalis and released into the extracellular milieu. A study from Campagnari and colleagues [15] found that one or two very large proteins with some similarity to the filamentous hemagglutinin (FhaB) of Bordetella pertussis could be found in M. catarrhalis culture supernatant fluid. Using the nucleotide sequence of the genome of M. catarrhalis ATCC 43617, Murphy and co-workers [20] identified a large number (i.e., 348) of proteins that had signal sequences, among which may be proteins that are released from the M. catarrhalis cell. Another group showed that M. catarrhalis culture supernatant fluid contained several different proteins as detected by SDS-PAGE analysis, but the identity of the individual proteins was not determined [21].
In the present study, we report the first identification of a bacteriocin that is produced by M. catarrhalis. Bacteriocins are proteins or peptides secreted or released by some bacteria that can effect both intraspecies and interspecies killing, and are responsible for some types of bacterial antagonism [for reviews see [22, 23]]. The locus encoding this peptide bacteriocin was identified initially in a M. catarrhalis plasmid and subsequently shown to be present in the chromosome of some M. catarrhalis strains. Four genes encoding the bacteriocin, relevant secretion factors, and a host immunity factor were shown to form a polycistronic operon (mcbABCI). This bacteriocin was shown to be active against M. catarrhalis strains lacking this operon. Recombinant methods were used to confirm the identity of the cognate immunity factor which does not resemble other proteins in the databases. In competitive co-culture assays, a M. catarrhalis strain expressing this bacteriocin became the predominant member of a mixed culture in which the other strain lacked the mcbABCI locus.
Results
M. catarrhalis strain E22 produces a factor that inhibits the growth of M. catarrhalisstrain O35E
Wild-type M. catarrhalis strain E22 was originally described as the host for the plasmid pLQ510 [24]. As reported previously [25], two of the ORFs in this plasmid were predicted to encode products with similarity to proteins involved in secretion of bacteriocins in other bacteria. Upon testing the E22 strain in a bacteriocin production assay using wild-type M. catarrhalis strain O35E as the indicator strain, the growth of the indicator strain was inhibited in the area immediately around the E22 strain (Figure 1C). In control experiments, O35E did not kill either itself (Figure 1A) or E22 (Figure 1B) and E22 did not kill itself (Figure 1D). This result indicated that strain E22 was capable of producing one or more factors that inhibited the growth of strain O35E.
Killing of M. catarrhalis O35E by M. catarrhalis E22 carrying pLQ510. Test strains and indicator strains were grown on BHI agar plates as described in Materials and Methods. Panels: A, O35E test strain on O35E indicator; B, O35E test strain on E22 indicator; C, E22 test strain on O35E indicator; D, E22 test strain on E22 indicator. The white arrow in panel C indicates the zone of killing of the indicator strain by the test strain. Panel E, schematic of pLQ510 indicating the four ORFs located in the mcb locus. The nucleotide sequence of pLQ510 is available at GenBank under accession no. AF129811. The positions of the restriction sites used to insert kanamycin resistance cassettes in the mcbB and mcbC genes are indicated.
Characterization of relevant protein products encoded by pLQ510
In a previous publication [25], ORF1 (now designated as M. c atarrhalis bacteriocin gene A or mcbA) in pLQ510 (Figure 1E) was described as encoding a protein with homology to the colicin V secretion protein of E. coli [26] whereas ORF2 (now designated mcbB) (Figure 1E) encoded a protein that was most similar to the colicin V secretion ATP-binding protein CvaB [26]. Analysis of the similarities between the amino acid sequences of the McbA and McbB proteins and those of proteins in sequence databases was next assessed using BLAST [blastp and PSI-BLAST [27]]. Both McbA and McbB were found to be members of well-populated protein families. McbA belongs to the HlyD family of so-called membrane-fusion proteins (MFPs). These proteins form a periplasm-spanning tube that extends from an ABC-type transporter in the plasma membrane to a TolC-like protein in the outer membrane [28]. An alignment [29] of McbA to E. coli HlyD showed that the two proteins are approximately 19% identical. Likewise, the primary structure of McbB is similar to that of the E. coli protein HlyB protein; their sequence identity is ~27%. HlyB is an ABC-type transporter that is presumably dimeric. It has two main domains: the N-terminal domain spans the plasma membrane, facilitating the export of its cognate substrate, while the C-terminal domain uses the energy of ATP hydrolysis to drive the export of the substrate against a concentration gradient [28]. Although the degree of sequence identity between the M. catarrhalis and E. coli proteins is modest, it is not unreasonable to assume that they may share analogous functions.
Identification of the M. catarrhalisbacteriocin and immunity factor genes
Immediately downstream from mcbB, two overlap** and small putative ORFs were detected. The first of these, designated mcbC (Figure 1E), contained 303-nt in pLQ510 and was predicted to encode a protein containing 101 amino acids (Figure 2A). BLAST analysis showed that this polypeptide had little similarity to other proteins or known bacteriocins. However, examination of the sequence of amino acids 25-39 in this protein revealed that it was similar to the leader sequence of the double-glycine (GG) bacteriocin family including E. coli colicin V (CvaC) and other double-glycine peptides of both gram-negative and gram-positive bacteria [50] using primers AA262 and AA250. The new PCR product was used in a plate transformation system [51] to transform M. catarrhalis strain O12E. Transformants were screened by colony-PCR using primers AA262 and AA251 (5'-AGATTGCTCACTCGTCCAC-3'); this latter primer binds downstream of AA250. One transformant shown to contain the desired deletion in the mcbA gene was designated O12EΔmcbA.
For the construction of an in-frame deletion in the mcbB ORF, primers AA247 (5'-TGCCATTGCCAAAGAGAC-3') and AA346 (5'-AATATTCTTTAAAAAATC CAT-3') were used to amplify 830 nt upstream of the mcbB ORF together with the first 21 nt of the mcbB ORF using chromosomal DNA from strain O12E as the template. In addition, primers AA347 (5'-TTTTTAAAGAATATTAGCACTGATT GGGTACTGAACCTTGGTTAA-3') and AA254 (5'-GGGCTTTGGGCGGTA GGTTATTA-3') were used to amplify the last 30 nt of the mcbB ORF and 769 nt of the downstream region. Both PCR fragments were used as templates for an overlap** extension PCR using primers AA247 and AA254; the resultant amplicon was designated 247-254. Wild-type strain O12E was first transformed with a PCR amplicon obtained by using primers AA248 (5'-CTGTTGCCAAAACTGCTC-3') and AA252 (5'-GCACATTGTTCCACCCATTCA-3') with plasmid pLQ510.mcbB::kan as the template; this amplicon contained the mcbB gene and the inserted kan cartridge. One of the resultant kanamycin-resistant transformants (O12E.mcbB::kan) was subsequently transformed with the 247-254 amplicon. Transformants were screened for the loss of kanamycin resistance and one kanamycin-sensitive transformant was selected for further study and designated as O12EΔmcbB.
To construct an in-frame deletion in the mcbC ORF, the same strategy was employed as was used for construction of the O12EΔmcbB mutant. The primer pair AA249 (5'-TTAGACCC AAGTGCTGGAC-3') and AA344 (5'-ACGCATAATATATTCCTTT AT-3') and the primer pair AA345 (5'-GAATATATTATGCGTATTATGGTTG GAGTTACTAAAAAATGGTAA-3') and AA254 were used in the initial PCR reactions with O12E chromosomal DNA, and the final amplicon containing a deletion in the mcbC ORF was used to transform an O12E mutant which had a kanamycin resistance cassette in its mcbC ORF (i.e., O12E.mcbC::kan). One kanamycin-sensitive transformant was selected for further characterization and was designated O12EΔmcbC. PCR and nucleotide sequence analysis were used to confirm that these three deletion mutations (i.e., in O12EΔmcbA, O12EΔmcbB, and O12EΔmcbC) were in-frame.
Reverse transcriptase-PCR
Possible transcriptional linkage among the ORFs in the mcb locus in pLQ510 was assessed by the use of reverse transcriptase-PCR. Total RNA was isolated from mid-logarithmic phase cells of M. catarrhalis E22 by using the RNeasy midi kit (Qiagen). RNA samples were treated with DNase I (Message Clean Kit, GenHunter Corp, Nashville, TN) to remove any DNA contamination. To amplify the region between the mcbA and mcbB ORFs, primers mcb A/B fw (5'-TAGCAGTTGGCATGACC TTG-3') and mcb A/B rv (5'-AGCAAGACAGGCTAGACCACA-3') were used. For the region between mcbB and mcbC, primers mcb B/C fw (5'-AGAGCGCTGATTG GGTACTG-3'), and mcb B/C rv (5'-CAT GCCATTGACTGACCAAC-3'), were used, and for the region between mcbC and mcbI, primers mcb C/I fw (5'-TCCTA ATAGATTGTCATATGGTGGTT-3') and mcb C/I rv (5'-CAAAACG TGCACA ATTAGGG-3') were used. The reverse transcriptase reaction was carried out using MultiScribe reverse transcriptase (Applied Biosystems, Foster City, CA) followed by PCR amplification. In addition, the reaction was also performed using either chromosomal DNA alone as the template or with the RNA template in the absence of reverse transcriptase.
Construction of a plasmid encoding a His-tagged McbC protein
In order to construct a plasmid that expressed the McbC protein with a C-terminal His-tag, the primer pair AA357 (5'-TGGGATCCGGTACTATTTAATGTACTAA GATTTT-3') (BamHI site underlined) and AA359 (5'-GTGGTGGTGGTGGTGGTG CCATTTTTTAGTAACTCCAACCATAAT-3') and the primer pair AA358 (5'-CACCACCACCACCACCACTAAAGACAATAGGTTTAGCATGGATAT-3') (mcbC translational stop codon underlined) and AA354 (5'-GGTTGAGCTCCCA TTTAAGTGATTTTGTTATATCAAT-3') (SacI site underlined) were used to generate two PCR products using O12E chromosomal DNA as the template. The resultant two PCR products were used as templates for an overlap** extension PCR involving primers AA357 and AA354. The final PCR amplicon was then digested with both BamHI and SacI and ligated into pWW115 [52] that had been digested with these same restriction enzymes. The ligation mixture was used to transform O12E.mcbC::kan. A plasmid isolated from a spectinomycin-resistant colony and which expressed the His-tagged McbC protein was designated pAA111. Plasmid pWW115 was used to transform M. catarrhalis O12E.mcbC::kan to provide a negative control.
Purification and detection of the His-tagged McbC protein
M. catarrhalis O12E.mcbC::kan(pWW115) and M. catarrhalis O12E.mcbC::kan(pAA111) were grown independently in 1 L BHI overnight at 37°C with shaking. The cultures were subjected to centrifugation to pellet the bacterial cells and the supernatant fluid was filter-sterilized. Two columns each containing 1.5 mL of NiNTA agarose beads (Qiagen, Valencia, CA) were washed with washing buffer (50 mM NaH2PO4, 200 mM NaCl, 5 mM imidazole [pH 7.9]). The culture supernatant fluids were passed through the columns twice after which the columns were washed with washing buffer again. The His-tagged protein was eluted using elution buffer (50 mM NaH2PO4, 200 mM NaCl, 200 mM imidazole [pH 7.9]). Selected fractions were pooled and dialyzed against PBS. SDS-digestion buffer was added to a final concentration of 1× to each sample. For Western blot analysis, proteins were resolved by SDS-PAGE using 15% (wt/vol) polyacrylamide separating gels and transferred to polyvinylidene difluoride membranes. The anti-His tag antibody HIS.H8 (Millipore, Temecula, CA) was used at a dilution of 1:2,000 in PBS-Tween containing 3% (wt/vol) dried milk and incubated with the membrane for 2 h at room temperature. Horseradish peroxidase-conjugated goat anti-mouse antibody (Jackson Immunoresearch, West Grove, PA) was used as the secondary antibody. The antigen-antibody complexes were detected by using Western Lightning Chemiluminescence Reagent Plus (New England Nuclear, Boston, MA).
Construction of a plasmid containing the mcbIgene
Primers AA353 (5'-ATGGATCCGAAAACTCATTGGGGAGATAGAGGGAT-3') (BamHI site underlined) and AA378 (5'-TTGTGAGCTCGCTCGGATTTGCTATTATTGA-3') (SacI site underlined) were used to PCR-amplify a 288-bp fragment containing the mcbI gene from M. catarrhalis O12E chromosomal DNA. The resultant PCR product was digested with both BamHI and SacI and ligated into pWW115 which had been digested with the same two restriction enzymes. This ligation mixture was used to transform M. catarrhalis strain O35E and transformants were selected for spectinomycin resistance. The plasmid from one of these transformants was designated pAA113.
Competitive index-based broth growth experiments
A streptomycin-resistant mutant of the wild-type strain O12E (O12E-Smr) [53] and the spectinomycin-resistant recombinant strains O35E(pWW115) and O35E(pAA113) were grown separately in MH broth to a density of approximately 108 CFU/ml. Equal volumes of O12E-Smrand the individual recombinant O35E strains were mixed in a 1:1 ratio. Serial dilutions of this mixture were plated on BHI agar plates containing the appropriate antibiotic to determine the relative percentages of each strain in the input mixture. Either a 1 ml or a 0.5 ml portion of the mixture was used to inoculate either 250 ml or 125 ml of MH broth, respectively, which was then allowed to grow overnight at 37°C with aeration. The cells were harvested after 18 h of growth, serially diluted, and plated on agar-based media containing the appropriate antibiotic to determine the relative percentage of each strain in the output mixture. A second set of competition experiments involving O12E-Smr and the spectinomycin-resistant mutant O35EΔmapA [34] was performed similarly. Each co-culture experiment was done three times independently; the data are the mean of the three experiments.
References
Catlin BW: Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin Microbiol Rev. 1990, 3: 293-320.
Karalus R, Campagnari A: Moraxella catarrhalis: a review of an important human mucosal pathogen. Microbes Infect. 2000, 2: 547-559. 10.1016/S1286-4579(00)00314-2.
Murphy TF: Bacterial otitis media: pathogenetic considerations. Pediatr Infect Dis J. 2000, 19: S9-15. 10.1097/00006454-200005001-00003.
Verduin CM, Hol C, Fleer A, van Dijk H, Van Belkum A: Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev. 2002, 15: 125-144. 10.1128/CMR.15.1.125-144.2002.
Wallace RJ, Musher DM: In honor of Dr. Sarah Branham, a star is born. The realization of Branhamella catarrhalis as a respiratory pathogen. Chest. 1986, 90: 447-450. 10.1378/chest.90.3.447.
Klein JO: Otitis media. Clin Infect Dis. 1994, 19: 823-833.
Murphy TF, Brauer AL, Grant BJ, Sethi S: Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease: Burden of Disease and Immune Response. Am J Respir Crit Care Med. 2005, 172: 195-199. 10.1164/rccm.200412-1747OC.
Forsgren A, Brant M, Karamehmedovic M, Riesbeck K: The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin. Infect Immun. 2003, 71: 3302-3309. 10.1128/IAI.71.6.3302-3309.2003.
Holm MM, Vanlerberg SL, Sledjeski DD, Lafontaine ER: The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells. Infect Immun. 2003, 71: 4977-4984. 10.1128/IAI.71.9.4977-4984.2003.
Lafontaine ER, Cope LD, Aebi C, Latimer JL, McCracken GH, Hansen EJ: The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro. J Bacteriol. 2000, 182: 1364-1373. 10.1128/JB.182.5.1364-1373.2000.
Reddy MS, Murphy TF, Faden HS, Bernstein JM: Middle ear mucin glycoprotein; purification and interaction with nontypeable Haemophilus influenzae and Moraxella catarrhalis. Otolaryngol Head Neck Surg. 1997, 116: 175-180. 10.1016/S0194-5998(97)70321-8.
Holm MM, Vanlerberg SL, Foley IM, Sledjeski DD, Lafontaine ER: The Moraxella catarrhalis Porin-Like Outer Membrane Protein CD Is an Adhesin for Human Lung Cells. Infect Immun. 2004, 72: 1906-1913. 10.1128/IAI.72.4.1906-1913.2004.
Luke NR, Jurcisek JA, Bakaletz LO, Campagnari AA: Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation. Infect Immun. 2007, 75: 5559-5564. 10.1128/IAI.00946-07.
Lipski SL, Akimana C, Timpe JM, Wooten RM, Lafontaine ER: The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain. Infect Immun. 2007, 75: 314-324. 10.1128/IAI.01330-06.
Plamondon P, Luke NR, Campagnari AA: Identification of a Novel Two-Partner Secretion Locus in Moraxella catarrhalis. Infect Immun. 2007, 75: 2929-2936. 10.1128/IAI.00396-07.
Wang W, Reitzer L, Rasko DA, Pearson MM, Blick RJ, Laurence C, et al: Metabolic Analysis of Moraxella catarrhalis and the Effect of Selected In Vitro Growth Conditions on Global Gene Expression. Infect Immun. 2007, 75: 4959-4971. 10.1128/IAI.00073-07.
Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, et al: Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA. 2006, 296: 202-211. 10.1001/jama.296.2.202.
Pearson MM, Laurence CA, Guinn SE, Hansen EJ: Biofilm formation by Moraxella catarrhalis in vitro: roles of the UspA1 adhesin and the Hag hemagglutinin. Infect Immun. 2006, 74: 1588-1596. 10.1128/IAI.74.3.1588-1596.2006.
Pearson MM, Hansen EJ: Identification of gene products involved in biofilm production by Moraxella catarrhalis ETSU-9 in vitro. Infect Immun. 2007, 75: 4316-4325. 10.1128/IAI.01347-06.
Ruckdeschel EA, Kirkham C, Lesse AJ, Hu Z, Murphy TF: Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection. Infect Immun. 2008, 76: 1599-1607. 10.1128/IAI.01253-07.
Fink J, Mathaba LT, Stewart GA, Graham PT, Steer JH, Joyce DA, et al: Moraxella catarrhalis stimulates the release of proinflammatory cytokines and prostaglandin E from human respiratory epithelial cells and monocyte-derived macrophages. FEMS Immunol Med Microbiol. 2006, 46: 198-208. 10.1111/j.1574-695X.2005.00022.x.
Riley MA, Wertz JE: Bacteriocin diversity: ecological and evolutionary perspectives. Biochimie. 2002, 84: 357-364. 10.1016/S0300-9084(02)01421-9.
Brook I: Bacterial interference. Crit Rev Microbiol. 1999, 25: 155-172. 10.1080/10408419991299211.
Beaulieu D, Ouellette M, Bergeron MG, Roy PH: Characterization of a plasmid isolated from Branhamella catarrhalis and detection of plasmid sequences within the genome of a B. catarrhalis strain. Plasmid. 1988, 20: 158-162. 10.1016/0147-619X(88)90020-0.
Liu L, Hansen EJ: Structural analysis of plasmid pLQ510 from Moraxella catarrhalis E22. Plasmid. 1999, 42: 150-153. 10.1006/plas.1999.1411.
Gilson L, Mahanty HK, Kolter R: Genetic analysis of an MDR-like export system: the secretion of colicin V. EMBO J. 1990, 9: 3875-3884.
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, et al: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25: 3389-3402. 10.1093/nar/25.17.3389.
Holland IB, Schmitt L, Young J: Type 1 protein secretion in bacteria, the ABC-transporter dependent pathway (review). Mol Membr Biol. 2005, 22: 29-39. 10.1080/09687860500042013.
Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al: Clustal W and Clustal X version 2.0. Bioinformatics. 2007, 23: 2947-2948. 10.1093/bioinformatics/btm404.
Michiels J, Dirix G, Vanderleyden J, ** C: Processing and export of peptide pheromones and bacteriocins in Gram-negative bacteria. Trends Microbiol. 2001, 9: 164-168. 10.1016/S0966-842X(01)01979-5.
Dirix G, Monsieurs P, Dombrecht B, Daniels R, Marchal K, Vanderleyden J, et al: Peptide signal molecules and bacteriocins in Gram-negative bacteria: a genome-wide in silico screening for peptides containing a double-glycine leader sequence and their cognate transporters. Peptides. 2004, 25: 1425-1440. 10.1016/j.peptides.2003.10.028.
Jones DT: Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol. 1999, 292: 195-202. 10.1006/jmbi.1999.3091.
Osborne MJ, Breeze AL, Lian LY, Reilly A, James R, Kleanthous C, et al: Three-dimensional solution structure and 13C nuclear magnetic resonance assignments of the colicin E9 immunity protein Im9. Biochemistry. 1996, 35: 9505-9512. 10.1021/bi960401k.
Hoopman TC, Wang W, Brautigam CA, Sedillo JL, Reilly TJ, Hansen EJ: Moraxella catarrhalis synthesizes an autotransporter that is an acid phosphatase. J Bacteriol. 2008, 190: 1459-1472. 10.1128/JB.01688-07.
Drider D, Fimland G, Hechard Y, McMullen LM, Prevost H: The continuing story of class IIa bacteriocins. Microbiol Mol Biol Rev. 2006, 70: 564-582. 10.1128/MMBR.00016-05.
De Vuyst L, Leroy F: Bacteriocins from lactic acid bacteria: production, purification, and food applications. J Mol Microbiol Biotechnol. 2007, 13: 194-199. 10.1159/000104752.
Havarstein LS, Diep DB, Nes IF: A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export. Mol Microbiol. 1995, 16: 229-240. 10.1111/j.1365-2958.1995.tb02295.x.
Ennahar S, Sashihara T, Sonomoto K, Ishizaki A: Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol Rev. 2000, 24: 85-106. 10.1111/j.1574-6976.2000.tb00534.x.
Maldonado A, Ruiz-Barba JL, Jimenez-Diaz R: Purification and genetic characterization of plantaricin NC8, a novel coculture-inducible two-peptide bacteriocin from Lactobacillus plantarum NC8. Appl Environ Microbiol. 2003, 69: 383-389. 10.1128/AEM.69.1.383-389.2003.
Mathiesen G, Huehne K, Kroeckel L, Axelsson L, Eijsink VG: Characterization of a new bacteriocin operon in sakacin P-producing Lactobacillus sakei, showing strong translational coupling between the bacteriocin and immunity genes. Appl Environ Microbiol. 2005, 71: 3565-3574. 10.1128/AEM.71.7.3565-3574.2005.
Johnsen L, Dalhus B, Leiros I, Nissen-Meyer J: 1.6-Angstroms crystal structure of EntA-im. A bacterial immunity protein conferring immunity to the antimicrobial activity of the pediocin-like bacteriocin enterocin A. J Biol Chem. 2005, 280: 19045-19050. 10.1074/jbc.M501386200.
Diep DB, Skaugen M, Salehian Z, Holo H, Nes IF: Common mechanisms of target cell recognition and immunity for class II bacteriocins. Proc Natl Acad Sci USA. 2007, 104: 2384-2389. 10.1073/pnas.0608775104.
Crupper SS, Gies AJ, Iandolo JJ: Purification and characterization of staphylococcin BacR1, a broad-spectrum bacteriocin. Appl Environ Microbiol. 1997, 63: 4185-4190.
Chuang DY, Chien YC, Wu HP: Cloning and expression of the Erwinia carotovora subsp. carotovora gene encoding the low-molecular-weight bacteriocin carocin S1. J Bacteriol. 2007, 189: 620-626. 10.1128/JB.01090-06.
Tiwari SK, Srivastava S: Purification and characterization of plantaricin LR14: a novel bacteriocin produced by Lactobacillus plantarum LR/14. Appl Microbiol Biotechnol. 2008, 79: 759-767. 10.1007/s00253-008-1482-6.
Dawid S, Roche AM, Weiser JN: The blp bacteriocins of Streptococcus pneumoniae mediate intraspecies competition both in vitro and in vivo. Infect Immun. 2007, 75: 443-451. 10.1128/IAI.01775-05.
Exley RM, Sim R, Goodwin L, Winterbotham M, Schneider MC, Read RC, et al: Identification of meningococcal genes necessary for colonisation of human upper airway tissue. Infect Immun. 2008, 77: 45-51. 10.1128/IAI.00968-08.
Kreth J, Merritt J, Shi W, Qi F: Co-ordinated bacteriocin production and competence development: a possible mechanism for taking up DNA from neighbouring species. Mol Microbiol. 2005, 57: 392-404. 10.1111/j.1365-2958.2005.04695.x.
Menard R, Sansonetti PJ, Parsot C: Nonpolar mutagenesis of the ipa genes defines IpaB, IpaC, and IpaD as effectors of Shigella flexneri entry into epithelial cells. J Bacteriol. 1993, 175: 5899-5906.
Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR: Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 1989, 77: 61-68. 10.1016/0378-1119(89)90359-4.
Juni E, Heym GA, Avery M: Defined medium for Moraxella (Branhamella) catarrhalis. Appl Environ Microbiol. 1986, 52: 546-551.
Wang W, Hansen EJ: Plasmid pWW115, a cloning vector for use with Moraxella catarrhalis. Plasmid. 2006, 56: 133-137. 10.1016/j.plasmid.2006.03.002.
Attia AS, Hansen EJ: A conserved tetranucleotide repeat is necessary for wild-type expression of the Moraxella catarrhalis UspA2 protein. J Bacteriol. 2006, 188: 7840-7852. 10.1128/JB.01204-06.
Unhanand M, Maciver I, Ramilo O, Arencibia-Mireles O, Argyle JC, McCracken GH, et al: Pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis. 1992, 165: 644-650.
Cope LD, Lafontaine ER, Slaughter CA, Hasemann CA, Aebi C, Henderson FW, et al: Characterization of the Moraxella catarrhalis uspA1 and uspA2 genes and their encoded products. J Bacteriol. 1999, 181: 4026-4034.
Murphy TF: Studies of the outer membrane proteins of Branhamella catarrhalis. Am J Med. 1990, 88 (5A): 41S-45S. 10.1016/0002-9343(90)90261-B.
Luke NR, Russo TA, Luther N, Campagnari AA: Use of an isogenic mutant constructed in Moraxella catarrhalis to identify a protective epitope of outer membrane B1 defined by monoclonal antibody 11C6. Infect Immun. 1999, 67: 681-687.
Soto-Hernandez JL, Holtsclaw-Berk S, Harvill LM, Berk SL: Phenotypic characteristics of Branhamella catarrhalis strains. J Clin Microbiol. 1989, 27: 903-908.
Meier PS, Troller R, Grivea IN, Syrogiannopoulos GA, Aebi C: The outer membrane proteins UspA1 and UspA2 of Moraxella catarrhalis are highly conserved in nasopharyngeal isolates from young children. Vaccine. 2002, 20: 1754-1760. 10.1016/S0264-410X(02)00030-0.
Acknowledgements
This study was supported by U.S. Public Health Service grants no. AI36344 to EJH and AI76365 to TCH. The authors thank John Nelson, Steven Berk, Frederick Henderson, Anthony Campagnari, Timothy Murphy, Merja Helminen, David Goldblatt, and Richard Wallace for providing the clinical isolates of M. catarrhalis used in this study.
Author information
Authors and Affiliations
Corresponding author
Additional information
Authors' contributions
ASA, LL, and EJH conceived of the study and participated in its design. ASA and LL designed, constructed, and characterized mutants. JLS designed and executed the competition experiments, and performed additional mutant analyses. TCH and WL designed and executed RT-PCR experiments. CAB performed analysis of protein structure and provided bioinformatics. ASA and EJH drafted the manuscript. All authors read and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Attia, A.S., Sedillo, J.L., Hoopman, T.C. et al. Identification of a bacteriocin and its cognate immunity factor expressed by Moraxella catarrhalis. BMC Microbiol 9, 207 (2009). https://doi.org/10.1186/1471-2180-9-207
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/1471-2180-9-207